(3S,5S)-Atorvastatin Sodium Salt

Name	(3S,5S)-Atorvastatin
Synonyms	S,S-Atorvastatin (3S,5S)-Atorvastatin 3S,5S-Atorvastatin Sodium (3S,5S)-Atorvastatin Sodium Salt Atorvastatin USP Related CoMpound E (bS,dS)-2-(4-Fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βS,δS)- (S,dS)-2-(4-Fluorophenyl)-,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium (βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrole-1-heptanoic Acid SodiuM
CAS	501121-34-2

Molecular Formula	C33H35FN2O5
Molar Mass	558.64
Melting Point	182-184°C
Solubility	DMSO (Slightly), Methanol (Slightly)
Appearance	Solid
Color	White
Storage Condition	-20°C Freezer
Stability	Hygroscopic
In vitro study	Atorvastatin and its inactive enantiomer (3S,5S)-Atorvastatin increases CYP2B and CYP3A mRNA content with equal ability. (3S,5S)-Atorvastatin in 100 μM concentrations induces luciferase activity with an EC 50 of 12.4 μM. Addition of (3S,5S)-Atorvastatin to the 2-formylphenylboronic acid (FPBA)/l-tryptophanol mixture induces an intensity enhancement of l-tryptophanol florescence.